NCT01543776View on ClinicalTrials.gov

Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2017

Study Completion Date

December 31, 2017

Conditions
Castration-resistant Prostate CancerStage IV Prostate Cancer
Interventions
DRUG

abiraterone acetate

Given PO

Trial Locations (6)

30322

Emory University Winship Cancer Institute, Atlanta

60201

North Shore University Health System, Evanston

60430

Ingalls Memorial Hospital, Harvey

61615

Illinois Cancer Care, Peoria

60637-1470

University of Chicago, Chicago

Unknown

National University Hospital, Singapore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Chicago

OTHER

NCT01543776 - Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer | Biotech Hunter | Biotech Hunter